Haemonetics' Surgical Disposables Sales Down 5%; Total Sales Up

Surgical disposables revenues for Haemonetics Corp. were down 5 percent in fiscal 2011, due to a declining number of surgical procedures, but overall revenues were up, the company said in a release.

Overall, Haemonetics showed a net 5 percent increase in revenues for the year while revenue in the fourth quarter was up 1 percent.  

Revenues for the company's OrthoPAT orthopedic perioperative autotransfusion system disposables were down 4 percent, diagnostics revenue was up 16 percent, and software Solutions revenue was up 86 percent. The company integrated its acquisition of Global Med and significantly enhanced its software products for blood bank and hospital customers.

Equipment and other revenue were up 7 percent and placements of equipment under use plans were strong, with a 7 percent total growth rate among hospitals during FY 2011.

Read the release on Haemonetics Corp.

Related Articles on Blood Products:
Critical Importance of the Perioperative Director to OR Efficiency: Q&A With Dr. Timothy Dowd of North American Partners in Anesthesia
Internal Review at University of New Mexico Health Sciences Center Refutes Surgeon's Claims of Substandard Care
AANS: 8% of Adult Spinal Surgeries Result in Major Complications




Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers